Pharma tax news - Vol. 5, No. 7 - August 2006

Accounting for uncertainty in income taxes, FAS B Interpretation No. 48 from a 482 Perspective

FAS B Interpretation 48 (FIN 48), governing the review of tax provisions with respect to “uncertain tax positions,” is among the most significant developments to affect corporate tax departments in recent years.



Publications Search Page
Contacts
Global
Simon Friend
Pharmaceuticals and life sciences leader
Tel: +44 (20) 7213 4875
Mike Swanick
Pharmaceuticals and life sciences tax leader
Tel: +1 (267) 330 6060
Steve Arlington
Pharmaceuticals and life sciences advisory leader
Tel: +44 (20) 7804 3997
 

© 2006-2008 PricewaterhouseCoopers. All rights reserved. PricewaterhouseCoopers refers to the network of member firms of PricewaterhouseCoopers International Limited, each of which is a separate and independent legal entity.
Accessibility information Skip navigation Countries online